Search

  • Order Status
  • Quick Order
  • Promos

Risk Mitigation and Compliance in Bioprocessing

Supporting compliance from development to manufacturing

Advancing bioprocesses from development to manufacturing requires consistent attention to regulatory compliance as workflows evolve. As cell lines adapt, media formulations change, equipment is updated, and processes are transferred between sites. Maintaining documentation readiness becomes increasingly complex. Embedding risk mitigation directly into bioprocessing workflows helps reduce rework, limit disruption, and support a more predictable scale-up. By aligning quality systems, standardized processes, and regulatory documentation early, teams can maintain regulatory readiness as programs progress toward manufacturing.

Embedding regulatory readiness into process design

Considering regulatory requirements during process design helps reduce downstream processing (DSP) risk and avoid late-stage changes that can delay development timelines. Selecting materials already supported by regulatory documentation and aligned with a resilient global supply network enables greater supply continuity as processes scale. Establishing standardized procedures and connecting quality controls from the outset supports smoother scale-up and technology transfer. Early regulatory alignment and supply continuity help maintain process consistency.

Regulatory documentation within your workflow

Integrating regulatory documentation into bioprocessing workflows supports confident planning, execution, and technology transfer by making product and quality information readily available. Thermo Fisher Scientific offers Drug Master Files (DMFs) for U.S. submissions and Regulatory Support Files (RSFs) for other regions, helping teams manage regulatory expectations consistently as processes scale and transfer.
 

 

Drug Master Files
 

Drug Master Files contain confidential information about facilities, processes, and raw materials submitted to the U.S. Food and Drug Administration. Thermo Fisher Scientific maintains DMFs for many cell culture media products used in further manufacturing. These files may be referenced in Investigational New Drug (IND) applications, Biologics License Applications (BLA), New Drug Applications (NDA), and Abbreviated New Drug Applications (ANDA), supporting regulatory submissions without requiring disclosure of proprietary manufacturing details.


 

Regulatory Support Files
 

Regulatory Support Files offer detailed product performance, stability, quality control, and analytical testing information for regions without an equivalent DMF mechanism. Available for select products used in regulated environments, RSFs are given for customer review under confidentiality agreements. These files support regulatory submissions outside the United States while helping teams maintain documentation continuity across global development and manufacturing sites.

Quality systems aligned across global operations

Aligned quality systems across global manufacturing operations help support consistent execution in regulated environments. Thermo Fisher Scientific operates harmonized quality systems that apply common procedures, controls, and documentation practices across facilities worldwide. This alignment supports consistent material performance regardless of manufacturing location and helps maintain confidence in quality, supply continuity, and regulatory documentation readiness.

Standardized processes to support consistent outcomes

Standardized processes and controls help reduce variability and support reproducible outcomes as bioprocesses move from development to manufacturing. By designing systems and materials with defined performance characteristics, Thermo Fisher Scientific enables teams to establish protocols that transfer reliably across teams, equipment platforms, and facilities. This standardization helps minimize deviations and streamline troubleshooting, while supporting efforts to optimize process efficiency across workflows.

Enabling confident technology transfer

Technology transfer is one of the highest-risk transition points in bioprocessing, as processes move between development teams, manufacturing sites, or contract development manufacturing organizations (CDMOs). Process knowledge must be transferred accurately, materials must perform consistently at different sites, and regulatory documentation must remain current throughout the transition. Thermo Fisher Scientific supports confident technology transfer through harmonized quality systems, standardized processes, and accessible regulatory documentation.

Request regulatory support files

Request Access to a DMF Letter of Authorization (LOA) or a CTS Regulatory Support File (RSF)

For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.